论文部分内容阅读
目前,临床根据TNM分期来判断Ⅲ期结肠癌患者是否进行辅助化疗。临床N分期越高,患者预后越差。有研究显示,淋巴结转移率比TNM分期能更好地预测患者预后。为了验证研究结论的正确与否,Schiffmann L等人收集了在2000~2009年期间接受根治术的142例Ⅲ期结肠癌患者的信息,并根据淋巴结转移率分成两组——低淋巴结转移率组和高淋巴结转移率
At present, the clinical stage according to TNM to determine whether patients with stage Ⅲ colon cancer adjuvant chemotherapy. The higher the clinical N stage, the worse the prognosis of patients. Some studies have shown that lymph node metastasis rate better than TNM stage prognosis prognosis. To verify the validity of the study’s findings, Schiffmann L et al. Collected information on 142 patients with stage III colon cancer who underwent radical surgery between 2000 and 2009. They were divided into two groups according to their rates of lymph node metastasis - low lymph node metastasis group And high lymph node metastasis rate